Related Experiment Video
Updated: May 5, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
MRI in corticobasal degeneration
M Grisoli1, V Fetoni, M Savoiardo
1Departments of Neuroradiology, Istituto Nazionale Neurologico "C. Besta", Milano, ItalyDepartments of Neurology, Istituto Nazionale Neurologico "C. Besta", Milano, Italy.
Abstract:
Corticobasal degeneration is a degenerative disease characterized by asymmetric brain atrophy and clinically by asymmetric onset of an akinetic-rigid syndrome with apraxia, dysarthria and dysphagia. Diagnosis must be confirmed by autopsy. We have investigated the ability of MRI to detect asymmetric atrophy to support the clinical diagnosis and permit differential diagnosis against other degenerative disorders. Ten patients with clinical suspicion of corticobasal degeneration were studied by brain MRI, and the images were reviewed with the side of greater clinical involvement unknown to the reviewer. The original reports of MR scans were also reviewed. MRI demonstrates that cortical atrophy is asymmetric and more marked in the posterior frontal and mainly in the parietal regions on the side contralateral to the clinical symptoms. Asymmetry was rarely detected on the first reading. Our review of MRI findings demonstrates that it is possible to detect asymmetrical parietal atrophy, thus supporting the clinical diagnosis of corticobasal degeneration. It is essential to be aware of the disease and alert for asymmetries in order to discern the more involved side. No abnormalities were detected in the basal ganglia.
Insights
Magnetic resonance imaging (MRI) can detect asymmetric parietal atrophy, aiding the diagnosis of corticobasal degeneration. This neuroimaging technique supports clinical findings and helps differentiate it from other neurological disorders.
Area of Science:
- Neurology
- Neuroimaging
- Radiology
Background:
- Corticobasal degeneration (CBD) is a progressive neurological disorder.
- It presents with asymmetric motor symptoms and cognitive decline.
- Definitive diagnosis requires post-mortem examination.
Purpose of the Study:
- To evaluate the utility of MRI in detecting asymmetric brain atrophy in suspected CBD cases.
- To assess MRI's role in supporting clinical diagnosis and differential diagnosis.
Main Methods:
- Brain MRI was performed on ten patients with clinical suspicion of CBD.
- MRI scans were reviewed by a radiologist unaware of the clinical presentation side.
- Original MRI reports were also analyzed.
Main Results:
- MRI revealed asymmetric cortical atrophy, predominantly in the posterior frontal and parietal regions, contralateral to clinical symptoms.
- Asymmetry was often missed on initial readings.
- Review of MRI findings confirmed the ability to detect asymmetrical parietal atrophy.
Conclusions:
- MRI can detect asymmetrical parietal atrophy, supporting the clinical diagnosis of corticobasal degeneration.
- Radiologists must be vigilant for subtle asymmetries to aid in diagnosis.
- MRI findings help differentiate CBD from other neurodegenerative conditions.
More Related Videos
07:34Functional MRI in Conjunction with a Novel MRI-compatible Hand-induced Robotic Device to Evaluate Rehabilitation of Individuals Recovering from Hand Grip Deficits
Published on: November 23, 2019
11:06Bilateral Assessment of the Corticospinal Pathways of the Ankle Muscles Using Navigated Transcranial Magnetic Stimulation
Published on: February 19, 2019